Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0650
+0.0008 (1.25%)
Oct 21, 2025, 5:31 PM CET
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 7.23 million as of October 21, 2025. Its market cap has increased by 15.30% in one year.
Market Cap
7.23M
Enterprise Value
4.97M
Revenue
167.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 7.23M, a decrease of -98.19%. That is a compound annual growth rate of -19.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 7.23M | 28.57% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | 53.24M | 22.57% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 243.21B |
| Novartis AG | 201.75B |
| Lonza Group AG | 38.88B |
| Galderma Group AG | 32.50B |
| Alcon | 29.43B |
| Sandoz Group AG | 20.85B |
| Straumann Holding AG | 13.86B |
| Sonova Holding AG | 12.96B |